| Literature DB >> 26401706 |
Therese S Salameh1,2, Kristin M Bullock1, Isabel A Hujoel1, Michael L Niehoff3,4, Tami Wolden-Hanson1, Junghyun Kim3, John E Morley3, Susan A Farr3,4, William A Banks1,2.
Abstract
Intranasal insulin has shown efficacy in patients with Alzheimer's disease (AD), but there are no preclinical studies determining whether or how it reaches the brain. Here, we showed that insulin applied at the level of the cribriform plate via the nasal route quickly distributed throughout the brain and reversed learning and memory deficits in an AD mouse model. Intranasal insulin entered the blood stream poorly and had no peripheral metabolic effects. Uptake into the brain from the cribriform plate was saturable, stimulated by PKC inhibition, and responded differently to cellular pathway inhibitors than did insulin transport at the blood-brain barrier. In summary, these results show intranasal delivery to be an effective way to deliver insulin to the brain.Entities:
Keywords: Alzheimer’s disease; cognition; insulin; intranasal administration
Mesh:
Substances:
Year: 2015 PMID: 26401706 PMCID: PMC6080853 DOI: 10.3233/JAD-150307
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472